Enterprise Innovation Institute

NHS England selects Terumo’s treatment for sickle cell disease

Posted on: June 24, 2022

Terumo Blood and Cell Technologies has announced that NHS England has selected the automated red blood cell exchange (RBCX) procedure performed on the Spectra Optia Apheresis System through the NHS MedTech Funding Mandate to treat sickle cell disease

Read full post: Read More